Addiction (English Wikipedia)

Burraway J (October 2020). "Addiction". In Stein F, Diemberger H, Stasch R, Robbins J, Sanchez A, Lazar S, Candea M (eds.). Open Encyclopedia of Anthropology. doi:10.29164/20addiction. S2CID 241689890.

apa.org (Global: 1,327^th place; English: 1,093^rd place)

doi.apa.org

Tiffany ST (1990). "A cognitive model of drug urges and drug-use behavior: Role of automatic and nonautomatic processes". Psychological Review. 97 (2): 147–168. doi:10.1037/0033-295X.97.2.147. ISSN 1939-1471. PMID 2186423.

arxiv.org (Global: 49^th place; English: 31^st place)

Fehrman E, Egan V, Gorban AN, Levesley J, Mirkes EM, Muhammad AK (2019). Personality Traits and Drug Consumption. A Story Told by Data. Springer, Cham. arXiv:2001.06520. doi:10.1007/978-3-030-10442-9. ISBN 978-3-030-10441-2. S2CID 151160405.

books.google.com (Global: 3^rd place; English: 3^rd place)

Lemon R (2018). "Introduction: Addiction in (Early) Modernity". Addiction and Devotion in Early Modern England. Haney Foundation Series. Philadelphia: University of Pennsylvania Press. pp. 1–23. ISBN 978-0-8122-4996-5.

cdc.gov (Global: 251^st place; English: 248^th place)

National Center for Health Statistics (13 May 2026). "U.S. Overdose Deaths Decrease for Third Consecutive Year in 2025". Centers for Disease Control and Prevention.

crafft.org (Global: low place; English: low place)

"Use the CRAFFT – CRAFFT". Retrieved 3 December 2022.

doi.org (Global: 2^nd place; English: 2^nd place)

Yu T, Wang M, Zheng J, Guan S, Chen J (April 2026). "Global substance use disorders burden from 1990 to 2021: post-COVID shifts and widening inequalities". Journal of Global Health. 16 04131. doi:10.7189/jogh.16.04131. PMC 13107084. PMID 42026948.
Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJ (September 2021). "Addiction as a brain disease revised: why it still matters, and the need for consilience". Neuropsychopharmacology. 46 (10): 1715–1723. doi:10.1038/s41386-020-00950-y. ISSN 0893-133X. PMC 8357831. PMID 33619327. pre-existing vulnerabilities and persistent drug use lead to a vicious circle of substantive disruptions in the brain that impair and undermine choice capacities for adaptive behavior, but do not annihilate them.
Volkow ND, Blanco C (June 2023). "Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention". World Psychiatry. 22 (2): 203–229. doi:10.1002/wps.21073. PMC 10168177. PMID 37159360.
Nestler EJ (December 2013). "Cellular basis of memory for addiction". Dialogues in Clinical Neuroscience. 15 (4): 431–443. doi:10.31887/DCNS.2013.15.4/enestler. PMC 3898681. PMID 24459410.
Heather N, Best D, Kawalek A, Field M, Lewis M, Rotgers F, et al. (July 2018). "Challenging the brain disease model of addiction: European launch of the addiction theory network". Addiction Research & Theory. 26 (4): 249–255. doi:10.1080/16066359.2017.1399659.
Lewis M (October 2018). Longo DL (ed.). "Brain Change in Addiction as Learning, Not Disease". The New England Journal of Medicine. 379 (16): 1551–1560. doi:10.1056/NEJMra1602872. hdl:1807/97270. PMID 30332573. S2CID 205117578.
Brand M, Antons S, Bőthe B, Demetrovics Z, Fineberg NA, Jimenez-Murcia S, et al. (February 2025). "Current Advances in Behavioral Addictions: From Fundamental Research to Clinical Practice". The American Journal of Psychiatry. 182 (2): 155–163. doi:10.1176/appi.ajp.20240092. PMID 39659159.
Gearhardt AN, Schulte EM (October 2021). "Is food addictive? A review of the science". Annual Review of Nutrition. 41: 387–410. doi:10.1146/annurev-nutr-110420-111710. PMID 34152831.
Verhulst B, Neale MC, Kendler KS (April 2015). "The heritability of alcohol use disorders: a meta-analysis of twin and adoption studies". Psychological Medicine. 45 (5): 1061–1072. doi:10.1017/S0033291714002165. PMC 4345133. PMID 25171596.
Bogdan R, Hatoum AS, Johnson EC, Agrawal A (January 2023). "The Genetically Informed Neurobiology of Addiction (GINA) model". Nature Reviews Neuroscience. 24 (1): 40–57. doi:10.1038/s41583-022-00656-8. PMC 10041646. PMID 36446900.
MacKillop J, Agabio R, Feldstein Ewing SW, Heilig M, Kelly JF, Leggio L, et al. (December 2022). "Hazardous drinking and alcohol use disorders". Nature Reviews. Disease Primers. 8 (1) 80. doi:10.1038/s41572-022-00406-1. PMC 10284465. PMID 36550121.
Volkow ND, Michaelides M, Baler R (October 2019). "The Neuroscience of Drug Reward and Addiction". Physiological Reviews. 99 (4): 2115–2140. doi:10.1152/physrev.00014.2018. PMC 6890985. PMID 31507244.
Mattick RP, Breen C, Kimber J, Davoli M (February 2014). "Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence". The Cochrane Database of Systematic Reviews. 2014 (2) CD002207. doi:10.1002/14651858.CD002207.pub4. PMC 10617756. PMID 24500948.
McPheeters M, O'Connor EA, Riley S, Kennedy SM, Voisin C, Kuznacic K, et al. (November 2023). "Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis". JAMA. 330 (17): 1653–1665. doi:10.1001/jama.2023.19761. PMC 10630900. PMID 37934220.
Lindson N, Theodoulou A, Ordóñez-Mena JM, Fanshawe TR, Sutton AJ, Livingstone-Banks J, et al. (September 2023). "Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses". The Cochrane Database of Systematic Reviews. 2023 (9) CD015226. doi:10.1002/14651858.CD015226.pub2. PMC 10495240. PMID 37696529.
De Crescenzo F, Ciabattini M, D'Alò GL, De Giorgi R, Del Giovane C, Cassar C, et al. (December 2018). "Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis". PLOS Medicine. 15 (12) e1002715. doi:10.1371/journal.pmed.1002715. PMC 6306153. PMID 30586362.
Colledge-Frisby S, Ottaviano S, Webb P, Grebely J, Wheeler A, et al. (May 2023). "Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review". Lancet Global Health. 11 (5): e673–e683. doi:10.1016/S2214-109X(23)00058-X. PMC 12765503. PMID 36996860.
Fleury MJ, Djouini A, Huynh C, Tremblay J, Ferland F, Ménard JM, et al. (November 2016). "Remission from substance use disorders: a systematic review and meta-analysis". Drug and Alcohol Dependence. 168: 293–306. doi:10.1016/j.drugalcdep.2016.08.625. PMID 27614380.
GBD 2023 Diseases and Injuries Collaborators (October 2025). "Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023". Lancet. 406 (10513): 1873–1922. doi:10.1016/S0140-6736(25)01637-X. PMC 12535840. PMID 41092926.
Merikangas KR, McClair VL (June 2012). "Epidemiology of Substance Use Disorders". Hum. Genet. 131 (6): 779–89. doi:10.1007/s00439-012-1168-0. PMC 4408274. PMID 22543841.
Singer M (October 2012). "Anthropology and addiction: an historical review". Addiction. 107 (10): 1747–1755. doi:10.1111/j.1360-0443.2012.03879.x. PMID 22962955.
Athey A, Shaff J, Kahn G, Brodie K, Ryan TC, Sawyer H, et al. (March 2025). "Association of substance use with suicide mortality: An updated systematic review and meta-analysis". Drug and Alcohol Dependence Reports. 14 100310. doi:10.1016/j.dadr.2024.100310. PMC 11741031. PMID 39830682.
Destoop M, Morrens M, Coppens V, Dom G (2019). "Addiction, anhedonia, and comorbid mood disorder. A narrative review". Frontiers in Psychiatry. 10 311. doi:10.3389/fpsyt.2019.00311. PMC 6538808. PMID 31178763.
Volkow ND, Koob GF, McLellan AT (January 2016). "Neurobiologic Advances from the Brain Disease Model of Addiction". New England Journal of Medicine. 374 (4): 363–371. doi:10.1056/NEJMra1511480. PMC 6135257. PMID 26816013. Substance-use disorder: A diagnostic term in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) referring to recurrent use of alcohol or other drugs that causes clinically and functionally significant impairment, such as health problems, disability, and failure to meet major responsibilities at work, school, or home. Depending on the level of severity, this disorder is classified as mild, moderate, or severe.
Addiction: A term used to indicate the most severe, chronic stage of substance-use disorder, in which there is a substantial loss of self-control, as indicated by compulsive drug taking despite the desire to stop taking the drug. In the DSM-5, the term addiction is synonymous with the classification of severe substance-use disorder.
Drummond DC (2001). "Theories of drug craving, ancient and modern". Addiction. 96 (1): 33–46. doi:10.1046/j.1360-0443.2001.961333.x. PMID 11177518.
Olsen CM (December 2011). "Natural rewards, neuroplasticity, and non-drug addictions". Neuropharmacology. 61 (7): 1109–22. doi:10.1016/j.neuropharm.2011.03.010. PMC 3139704. PMID 21459101.
Gearhardt AN, Bueno NB, DiFeliceantonio AG, Roberto CA, Jiménez-Murcia S, Fernandez-Aranda F (October 2023). "Social, clinical, and policy implications of ultra-processed food addiction". BMJ. 383 e075354. doi:10.1136/bmj-2023-075354. PMC 10561019. PMID 37813420.
di Giacomo E, Aliberti F, Pescatore F, Santorelli M, Pessina R, Placenti V, et al. (August 2022). "Disentangling binge eating disorder and food addiction: a systematic review and meta-analysis". Eating and Weight Disorders. 27 (6): 1963–1970. doi:10.1007/s40519-021-01354-7. PMC 9287203. PMID 35041154.
Vassoler FM, Sadri-Vakili G (2014). "Mechanisms of transgenerational inheritance of addictive-like behaviors". Neuroscience. 264: 198–206. doi:10.1016/j.neuroscience.2013.07.064. PMC 3872494. PMID 23920159.
Saunders GR, Wang X, Chen F, Jang SK, Liu M, Wang C, et al. (December 2022). "Genetic diversity fuels gene discovery for tobacco and alcohol use". Nature. 612 (7941). Nature Research: 720–724. Bibcode:2022Natur.612..720S. doi:10.1038/s41586-022-05477-4. PMC 9771818. PMID 36477530. S2CID 254434507.
Skylstad V, Babirye JN, Kiguli J, Skar AS, Kühl MJ, Nalugya JS, et al. (March 2022). "Are we overlooking alcohol use by younger children?". BMJ Paediatrics Open. 6 (1) e001242. doi:10.1136/bmjpo-2021-001242. PMC 8905875. PMID 36053657.
Hughes K, Bellis MA, Hardcastle KA, Sethi D, Butchart A, Mikton C, et al. (August 2017). "The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis". The Lancet. Public Health. 2 (8): e356–e366. doi:10.1016/S2468-2667(17)30118-4. PMID 29253477.
Leza L, Siria S, López-Goñi JJ, Fernández-Montalvo J (April 2021). "Adverse childhood experiences (ACEs) and substance use disorder (SUD): a scoping review". Drug and Alcohol Dependence. 221 108563. doi:10.1016/j.drugalcdep.2021.108563. hdl:2454/39101. PMID 33561668.
Hill R, Harris J (2 November 2021). "Psychological Approaches to Addiction". In Day E (ed.). Seminars in addiction psychiatry (2nd ed.). Cambridge: Cambridge University Press. pp. 147–169. doi:10.1017/9781911623199.009. ISBN 978-1-911623-19-9. S2CID 242036830.
Enoch MA (March 2011). "The role of early life stress as a predictor for alcohol and drug dependence". Psychopharmacology. 214 (1): 17–31. doi:10.1007/s00213-010-1916-6. PMC 3005022. PMID 20596857.
Sinha R (August 2024). "Stress and substance use disorders: risk, relapse, and treatment outcomes". The Journal of Clinical Investigation. 134 (16) e172883. doi:10.1172/JCI172883. PMC 11324296. PMID 39145454.
Ruffle JK (November 2014). "Molecular neurobiology of addiction: what's all the (Δ)FosB about?". Am. J. Drug Alcohol Abuse. 40 (6): 428–37. doi:10.3109/00952990.2014.933840. PMID 25083822. S2CID 19157711.
Washburn DA (2016). "The Stroop effect at 80: The competition between stimulus control and cognitive control". J Exp Anal Behav. 105 (1): 3–13. doi:10.1002/jeab.194. PMID 26781048.
Diamond A (2013). "Executive functions". Annu Rev Psychol. 64: 135–68. doi:10.1146/annurev-psych-113011-143750. PMC 4084861. PMID 23020641.
Levy N (2019). "Chapter 5 Addiction: The belief oscillation hypothesis". In Pickard H, Ahmed SH (eds.). The Routledge handbook of philosophy and science of addiction. Wellcome Trust–Funded Monographs and Book Chapters. Oxon (UK): Routledge. doi:10.4324/9781315689197-6. ISBN 978-1-138-90928-1. OCLC 1042341025. PMID 31017751. S2CID 242067468.
Berridge KC, Kringelbach ML (May 2015). "Pleasure systems in the brain". Neuron. 86 (3): 646–664. doi:10.1016/j.neuron.2015.02.018. PMC 4425246. PMID 25950633.
Feltenstein MW, See RE (May 2008). "The neurocircuitry of addiction: an overview". British Journal of Pharmacology. 154 (2): 261–274. doi:10.1038/bjp.2008.51. PMC 2442446. PMID 18311189.
Perry CJ, Zbukvic I, Kim JH, Lawrence AJ (October 2014). "Role of cues and contexts on drug-seeking behaviour". British Journal of Pharmacology. 171 (20): 4636–72. doi:10.1111/bph.12735. PMC 4209936. PMID 24749941.
Berridge KC (April 2012). "From prediction error to incentive salience: mesolimbic computation of reward motivation". Eur. J. Neurosci. 35 (7): 1124–43. doi:10.1111/j.1460-9568.2012.07990.x. PMC 3325516. PMID 22487042.
Edwards S (2016). "Reinforcement principles for addiction medicine; from recreational drug use to psychiatric disorder". Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Constructs and Drugs. Progress in Brain Research. Vol. 223. pp. 63–76. doi:10.1016/bs.pbr.2015.07.005. ISBN 978-0-444-63545-7. PMID 26806771.
Robinson TE, Berridge KC (2025). "The Incentive-Sensitization Theory of Addiction 30 Years On". Annual Review of Psychology. 76 (1): 29–58. doi:10.1146/annurev-psych-011624-024031. PMC 11773642. PMID 39094061.
Nestler EJ, Barrot M, Self DW (September 2001). "DeltaFosB: a sustained molecular switch for addiction". Proc. Natl. Acad. Sci. U.S.A. 98 (20): 11042–46. doi:10.1073/pnas.191352698. PMC 58680. PMID 11572966.
Nestler EJ (October 2008). "Review. Transcriptional mechanisms of addiction: role of DeltaFosB". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 363 (1507): 3245–55. doi:10.1098/rstb.2008.0067. PMC 2607320. PMID 18640924.
Nestler EJ (January 2014). "Epigenetic mechanisms of drug addiction". Neuropharmacology. 76 (Pt B): 259–68. doi:10.1016/j.neuropharm.2013.04.004. PMC 3766384. PMID 23643695.
Walker DM, Cates HM, Heller EA, Nestler EJ (February 2015). "Regulation of chromatin states by drugs of abuse". Curr. Opin. Neurobiol. 30: 112–21. doi:10.1016/j.conb.2014.11.002. PMC 4293340. PMID 25486626.
Tiffany ST (1990). "A cognitive model of drug urges and drug-use behavior: Role of automatic and nonautomatic processes". Psychological Review. 97 (2): 147–168. doi:10.1037/0033-295X.97.2.147. ISSN 1939-1471. PMID 2186423.
Fehrman E, Egan V, Gorban AN, Levesley J, Mirkes EM, Muhammad AK (2019). Personality Traits and Drug Consumption. A Story Told by Data. Springer, Cham. arXiv:2001.06520. doi:10.1007/978-3-030-10442-9. ISBN 978-3-030-10441-2. S2CID 151160405.
Cheetham A, Allen NB, Yücel M, Lubman DI (August 2010). "The role of affective dysregulation in drug addiction". Clin Psychol Rev. 30 (6): 621–34. doi:10.1016/j.cpr.2010.04.005. PMID 20546986.
Dawe S, Loxton NJ (May 2004). "The role of impulsivity in the development of substance use and eating disorders". Neurosci Biobehav Rev. 28 (3): 343–51. doi:10.1016/j.neubiorev.2004.03.007. PMID 15225976. S2CID 24435589.
Smith MA (February 2021). "Social learning and addiction". Behavioural Brain Research. 398 112954. doi:10.1016/j.bbr.2020.112954. PMC 7719575. PMID 33053384.
Marcos AC, Bahr SJ (June 1988). "Control Theory and Adolescent Drug Use". Youth & Society. 19 (4): 395–425. doi:10.1177/0044118X88019004003. ISSN 0044-118X. S2CID 143860602.
Hunt A, Merola GP, Carpenter T, Jaeggi AV (April 2024). "Evolutionary perspectives on substance and behavioural addictions: Distinct and shared pathways to understanding, prediction and prevention". Neuroscience and Biobehavioral Reviews. 159 105603. doi:10.1016/j.neubiorev.2024.105603. PMID 38402919.
Nesse RM, Berridge KC (October 1997). "Psychoactive drug use in evolutionary perspective". Science. 278 (5335): 63–66. doi:10.1126/science.278.5335.63. PMID 9311928.
Durrant R, Adamson S, Todd F, Sellman D (13 November 2009). "Drug use and addiction: evolutionary perspective". Australian and New Zealand Journal of Psychiatry. 43 (11): 1049–1056. doi:10.3109/00048670903270449. ISSN 0004-8674. PMID 20001400.
Saah T (29 June 2005). "The evolutionary origins and significance of drug addiction". Harm Reduction Journal. 2 (1) 8. doi:10.1186/1477-7517-2-8. ISSN 1477-7517. PMC 1174878. PMID 15987511.
Sullivan RJ, Hagen EH, Hammerstein P (March 2008). "Revealing the paradox of drug reward in human evolution". Proceedings of the Royal Society B: Biological Sciences. 275 (1640): 1231–1241. doi:10.1098/rspb.2007.1673. PMC 2367444. PMID 18353749.
Volkow ND, Koob GF, McLellan AT (28 January 2016). "Neurobiologic Advances from the Brain Disease Model of Addiction". New England Journal of Medicine. 374 (4): 363–371. doi:10.1056/NEJMra1511480. ISSN 0028-4793. PMC 6135257. PMID 26816013.
Petry NM, Rehbein F, Gentile DA, Lemmens JS, Rumpf HJ, Mößle T, et al. (September 2014). "An international consensus for assessing internet gaming disorder using the new DSM-5 approach". Addiction. 109 (9): 1399–406. doi:10.1111/add.12457. PMID 24456155.
Han BH, Moore AA (February 2018). "Prevention and Screening of Unhealthy Substance Use by Older Adults". Clinics in Geriatric Medicine. 34 (1): 117–129. doi:10.1016/j.cger.2017.08.005. PMC 5718360. PMID 29129212.
Yudko E, Lozhkina O, Fouts A (March 2007). "A comprehensive review of the psychometric properties of the Drug Abuse Screening Test". Journal of Substance Abuse Treatment. 32 (2): 189–198. doi:10.1016/j.jsat.2006.08.002. PMID 17306727.
Kwako LE, Momenan R, Litten RZ, Koob GF, Goldman D (August 2016). "Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders". Biological Psychiatry. 80 (3): 179–189. doi:10.1016/j.biopsych.2015.10.024. PMC 4870153. PMID 26772405.
Fleury MJ, Djouini A, Huỳnh C, Tremblay J, Ferland F, Ménard JM, et al. (1 November 2016). "Remission from substance use disorders: A systematic review and meta-analysis". Drug and Alcohol Dependence. 168: 293–306. doi:10.1016/j.drugalcdep.2016.08.625. ISSN 0376-8716. Retrieved 31 August 2026.
Santo T, Clark B, Hickman M, Grebely J, Campbell G, Sordo L, et al. (September 2021). "Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis". JAMA Psychiatry. 78 (9): 979–993. doi:10.1001/jamapsychiatry.2021.0976. PMC 8173472. PMID 34076676.
Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, et al. (September 2017). "Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs". The Cochrane Database of Systematic Reviews. 2017 (9) CD012021. doi:10.1002/14651858.CD012021.pub2. PMC 5621373. PMID 28922449.
Kelly JF, Humphreys K, Ferri M (March 2020). "Alcoholics Anonymous and other 12-step programs for alcohol use disorder". The Cochrane Database of Systematic Reviews. 2020 (3) CD012880. doi:10.1002/14651858.CD012880.pub2. PMC 7065341. PMID 32159228.
Schmanke L (2019). "Art Therapy Applications and Substance Abuse". Art and Expressive Therapies within the Medical Model (1st ed.). Routledge. pp. 177–187. doi:10.4324/9780429400087-16. ISBN 978-0-367-02340-9.
Rockwell P, Dunham M (January 2006). "The Utility of the Formal Elements Art Therapy Scale in Assessment for Substance Use Disorder". Art Therapy. 23 (3): 104–111. doi:10.1080/07421656.2006.10129625. ISSN 0742-1656.
Megranahan K, Lynskey MT (February 2018). "Do creative arts therapies reduce substance misuse? A systematic review". The Arts in Psychotherapy. 57: 50–58. doi:10.1016/j.aip.2017.10.005. ISSN 0197-4556.
Schmanke L (2015). "Art Therapy and Substance Abuse". The Wiley Handbook of Art Therapy. John Wiley & Sons. pp. 361–374. doi:10.1002/9781118306543.ch35. ISBN 978-1-118-30654-3.
GBD 2016 Alcohol and Drug Use Collaborators (December 2018). "The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016". The Lancet. Psychiatry. 5 (12): 987–1012. doi:10.1016/S2215-0366(18)30337-7. PMC 6251968. PMID 30392731.
Chen CC, Yin SJ (October 2008). "Alcohol abuse and related factors in Asia". International Review of Psychiatry. 20 (5): 425–433. doi:10.1080/09540260802344075. PMID 19012127. S2CID 24571763.
Pacurucu-Castillo SF, Ordóñez-Mancheno JM, Hernández-Cruz A, Alarcón RD (April 2019). "World opioid and substance use epidemic: a Latin American perspective". Psychiatric Research and Clinical Practice. 1 (1): 32–8. doi:10.1176/appi.prcp.20180009. PMC 9175731. PMID 36101564.
Levine HG (1978). "The discovery of addiction: Changing conceptions of habitual drunkenness in America". Journal of Studies on Alcohol. 39 (1): 143–174. doi:10.15288/jsa.1978.39.143. PMID 344994.
Schütz CG, Ramírez-Vizcaya S, Froese T (2018). "The clinical concept of opioid addiction since 1877: Still wanting after all these years". Frontiers in Psychiatry. 9 508. doi:10.3389/fpsyt.2018.00508. PMC 6198080. PMID 30386269.
Alexander BK, Schweighofer AR (1988). "Defining "addiction"". Canadian Psychology. 29 (2): 151–162. doi:10.1037/h0079767.
Gowing L, Ali R, Allsop S, Marsden J, Turf E, West E, et al. (2015). "Global statistics on addictive behaviours: 2014 status report" (PDF). Addiction. 110 (6): 904–919. doi:10.1111/add.12899. PMID 25963869.
Lee C, Ko A, Yang F (2018). "Association of DSM-5 betel-quid use disorder with oral potentially malignant disorder in 6 betel-quid endemic Asian populations". JAMA Psychiatry. 75 (3): 261–269. doi:10.1001/jamapsychiatry.2017.4307. PMC 5885949. PMID 29417149.
Sahithya B, Kashyap R (2022). "Sexual Addiction Disorder—a review with recent updates". Journal of Psychosexual Health. 4 (2): 95–101. doi:10.1177/26318318221081080. S2CID 248835855.
Crocq MA (December 2007). Thibaut F (ed.). "Historical and cultural aspects of man's relationship with addictive drugs". Dialogues in Clinical Neuroscience. 9 (4). Laboratoires Servier: 355–361. doi:10.31887/DCNS.2007.9.4/macrocq. OCLC 62869913. PMC 3202501. PMID 18286796. S2CID 12682928.
Rosenthal R, Faris S (February 2019). "The etymology and early history of 'addiction'". Addiction Research & Theory. 27 (5). Taylor & Francis: 437–449. doi:10.1080/16066359.2018.1543412. ISSN 1476-7392. S2CID 150418396.
van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF (July 2013). "Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review". Drug and Alcohol Dependence. 131 (1–2): 23–35. doi:10.1016/j.drugalcdep.2013.02.018. PMID 23490450.
Magnan E, Weyrich M, Miller M, Melnikow J, Moulin A, Servis M, et al. (February 2024). "Stigma against patients with substance use disorders among health care professionals and trainees and stigma-reducing interventions: a systematic review". Academic Medicine. 99 (2): 221–231. doi:10.1097/ACM.0000000000005467. PMID 37801599.
Heath DB (September 1958). "Drinking patterns of the Bolivian Camba". Quarterly Journal of Studies on Alcohol. 19 (3): 491–508. doi:10.15288/qjsa.1958.19.491. PMID 13579177.
Burraway J (October 2020). "Addiction". In Stein F, Diemberger H, Stasch R, Robbins J, Sanchez A, Lazar S, Candea M (eds.). Open Encyclopedia of Anthropology. doi:10.29164/20addiction. S2CID 241689890.
Preble E, Casey JJ (January 1969). "Taking Care of Business—The Heroin User's Life on the Street". International Journal of the Addictions. 4 (1): 1–24. doi:10.3109/10826086909061998. ISSN 0020-773X.
Golub A, Johnson BD, Dunlap E (May 2005). "Subcultural evolution and illicit drug use". Addiction Research & Theory. 13 (3): 217–229. doi:10.1080/16066350500053497. PMC 3690817. PMID 23805068.
Hartmann-Boyce J, Cahill K, Hatsukami D, Cornuz J (August 2012). "Nicotine vaccines for smoking cessation". The Cochrane Database of Systematic Reviews. 2012 (8) CD007072. doi:10.1002/14651858.CD007072.pub2. PMC 6486305. PMID 22895958.
Stephenson RJ, Toth I (May 2023). "Anti-cocaine vaccine development: where are we now and where are we going?". Journal of Medicinal Chemistry. 66 (11): 7086–7100. doi:10.1021/acs.jmedchem.3c00366. PMID 37227096.
Qeadan F, McCunn A, Tingey B (2024). "The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysis". Addiction. 120 (2): 236–250. doi:10.1111/add.16679. PMC 11707322. PMID 39415416.
Leggio L, Hendershot CS, Farokhnia M, et al. (December 2023). "GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders". Nature Medicine. 29 (12): 2993–2995. doi:10.1038/s41591-023-02634-8. PMC 12320759. PMID 38001271.

drugabuse.gov (Global: low place; English: 9,769^th place)

"Drugs, Brains, and Behavior: The Science of Addiction – Drug Misuse and Addiction". www.drugabuse.gov. North Bethesda, Maryland: National Institute on Drug Abuse. 13 July 2020. Retrieved 23 December 2021.
"What are risk factors and protective factors?". National Institute on Drug Abuse. Archived from the original on 30 April 2020. Retrieved 13 December 2017.
"Understanding Drug Use and Addiction". www.drugabuse.gov. National Institute on Drug Abuse. 6 June 2018. Retrieved 29 May 2020.

dsm5.org (Global: low place; English: low place)

American Psychiatric Association (2013). "Substance-Related and Addictive Disorders" (PDF). American Psychiatric Publishing. pp. 1–2. Archived from the original (PDF) on 15 August 2015. Retrieved 8 April 2023. Additionally, the diagnosis of dependence caused much confusion. Most people link dependence with "addiction" when, in fact, dependence can be a normal body response to a substance.

hdl.handle.net (Global: 66^th place; English: 34^th place)

Lewis M (October 2018). Longo DL (ed.). "Brain Change in Addiction as Learning, Not Disease". The New England Journal of Medicine. 379 (16): 1551–1560. doi:10.1056/NEJMra1602872. hdl:1807/97270. PMID 30332573. S2CID 205117578.
Leza L, Siria S, López-Goñi JJ, Fernández-Montalvo J (April 2021). "Adverse childhood experiences (ACEs) and substance use disorder (SUD): a scoping review". Drug and Alcohol Dependence. 221 108563. doi:10.1016/j.drugalcdep.2021.108563. hdl:2454/39101. PMID 33561668.

incb.org (Global: low place; English: low place)

"Economic consequences of drug abuse" (PDF). International Narcotics Control Board Report: 2013 (PDF). United Nations – International Narcotics Control Board. 2013. ISBN 978-92-1-148274-4. Retrieved 28 September 2018.

nih.gov (Global: 5^th place; English: 5^th place)

pubmed.ncbi.nlm.nih.gov

Yu T, Wang M, Zheng J, Guan S, Chen J (April 2026). "Global substance use disorders burden from 1990 to 2021: post-COVID shifts and widening inequalities". Journal of Global Health. 16 04131. doi:10.7189/jogh.16.04131. PMC 13107084. PMID 42026948.
Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJ (September 2021). "Addiction as a brain disease revised: why it still matters, and the need for consilience". Neuropsychopharmacology. 46 (10): 1715–1723. doi:10.1038/s41386-020-00950-y. ISSN 0893-133X. PMC 8357831. PMID 33619327. pre-existing vulnerabilities and persistent drug use lead to a vicious circle of substantive disruptions in the brain that impair and undermine choice capacities for adaptive behavior, but do not annihilate them.
Volkow ND, Blanco C (June 2023). "Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention". World Psychiatry. 22 (2): 203–229. doi:10.1002/wps.21073. PMC 10168177. PMID 37159360.
Nestler EJ (December 2013). "Cellular basis of memory for addiction". Dialogues in Clinical Neuroscience. 15 (4): 431–443. doi:10.31887/DCNS.2013.15.4/enestler. PMC 3898681. PMID 24459410.
Lewis M (October 2018). Longo DL (ed.). "Brain Change in Addiction as Learning, Not Disease". The New England Journal of Medicine. 379 (16): 1551–1560. doi:10.1056/NEJMra1602872. hdl:1807/97270. PMID 30332573. S2CID 205117578.
Brand M, Antons S, Bőthe B, Demetrovics Z, Fineberg NA, Jimenez-Murcia S, et al. (February 2025). "Current Advances in Behavioral Addictions: From Fundamental Research to Clinical Practice". The American Journal of Psychiatry. 182 (2): 155–163. doi:10.1176/appi.ajp.20240092. PMID 39659159.
Gearhardt AN, Schulte EM (October 2021). "Is food addictive? A review of the science". Annual Review of Nutrition. 41: 387–410. doi:10.1146/annurev-nutr-110420-111710. PMID 34152831.
Verhulst B, Neale MC, Kendler KS (April 2015). "The heritability of alcohol use disorders: a meta-analysis of twin and adoption studies". Psychological Medicine. 45 (5): 1061–1072. doi:10.1017/S0033291714002165. PMC 4345133. PMID 25171596.
Bogdan R, Hatoum AS, Johnson EC, Agrawal A (January 2023). "The Genetically Informed Neurobiology of Addiction (GINA) model". Nature Reviews Neuroscience. 24 (1): 40–57. doi:10.1038/s41583-022-00656-8. PMC 10041646. PMID 36446900.
MacKillop J, Agabio R, Feldstein Ewing SW, Heilig M, Kelly JF, Leggio L, et al. (December 2022). "Hazardous drinking and alcohol use disorders". Nature Reviews. Disease Primers. 8 (1) 80. doi:10.1038/s41572-022-00406-1. PMC 10284465. PMID 36550121.
Volkow ND, Michaelides M, Baler R (October 2019). "The Neuroscience of Drug Reward and Addiction". Physiological Reviews. 99 (4): 2115–2140. doi:10.1152/physrev.00014.2018. PMC 6890985. PMID 31507244.
Mattick RP, Breen C, Kimber J, Davoli M (February 2014). "Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence". The Cochrane Database of Systematic Reviews. 2014 (2) CD002207. doi:10.1002/14651858.CD002207.pub4. PMC 10617756. PMID 24500948.
McPheeters M, O'Connor EA, Riley S, Kennedy SM, Voisin C, Kuznacic K, et al. (November 2023). "Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis". JAMA. 330 (17): 1653–1665. doi:10.1001/jama.2023.19761. PMC 10630900. PMID 37934220.
Lindson N, Theodoulou A, Ordóñez-Mena JM, Fanshawe TR, Sutton AJ, Livingstone-Banks J, et al. (September 2023). "Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses". The Cochrane Database of Systematic Reviews. 2023 (9) CD015226. doi:10.1002/14651858.CD015226.pub2. PMC 10495240. PMID 37696529.
De Crescenzo F, Ciabattini M, D'Alò GL, De Giorgi R, Del Giovane C, Cassar C, et al. (December 2018). "Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis". PLOS Medicine. 15 (12) e1002715. doi:10.1371/journal.pmed.1002715. PMC 6306153. PMID 30586362.
Colledge-Frisby S, Ottaviano S, Webb P, Grebely J, Wheeler A, et al. (May 2023). "Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review". Lancet Global Health. 11 (5): e673–e683. doi:10.1016/S2214-109X(23)00058-X. PMC 12765503. PMID 36996860.
Fleury MJ, Djouini A, Huynh C, Tremblay J, Ferland F, Ménard JM, et al. (November 2016). "Remission from substance use disorders: a systematic review and meta-analysis". Drug and Alcohol Dependence. 168: 293–306. doi:10.1016/j.drugalcdep.2016.08.625. PMID 27614380.
GBD 2023 Diseases and Injuries Collaborators (October 2025). "Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023". Lancet. 406 (10513): 1873–1922. doi:10.1016/S0140-6736(25)01637-X. PMC 12535840. PMID 41092926.
Merikangas KR, McClair VL (June 2012). "Epidemiology of Substance Use Disorders". Hum. Genet. 131 (6): 779–89. doi:10.1007/s00439-012-1168-0. PMC 4408274. PMID 22543841.
Singer M (October 2012). "Anthropology and addiction: an historical review". Addiction. 107 (10): 1747–1755. doi:10.1111/j.1360-0443.2012.03879.x. PMID 22962955.
Athey A, Shaff J, Kahn G, Brodie K, Ryan TC, Sawyer H, et al. (March 2025). "Association of substance use with suicide mortality: An updated systematic review and meta-analysis". Drug and Alcohol Dependence Reports. 14 100310. doi:10.1016/j.dadr.2024.100310. PMC 11741031. PMID 39830682.
Destoop M, Morrens M, Coppens V, Dom G (2019). "Addiction, anhedonia, and comorbid mood disorder. A narrative review". Frontiers in Psychiatry. 10 311. doi:10.3389/fpsyt.2019.00311. PMC 6538808. PMID 31178763.
Nestler EJ (December 2013). "Cellular basis of memory for addiction". Dialogues in Clinical Neuroscience. 15 (4): 431–443. PMC 3898681. PMID 24459410. Despite the importance of numerous psychosocial factors, at its core, drug addiction involves a biological process: the ability of repeated exposure to a drug of abuse to induce changes in a vulnerable brain that drive the compulsive seeking and taking of drugs, and loss of control over drug use, that define a state of addiction. ... A large body of literature has demonstrated that such ΔFosB induction in D1-type [nucleus accumbens] neurons increases an animal's sensitivity to drug as well as natural rewards and promotes drug self-administration, presumably through a process of positive reinforcement ... Another ΔFosB target is cFos: as ΔFosB accumulates with repeated drug exposure it represses c-Fos and contributes to the molecular switch whereby ΔFosB is selectively induced in the chronic drug-treated state.⁴¹ ... Moreover, there is increasing evidence that, despite a range of genetic risks for addiction across the population, exposure to sufficiently high doses of a drug for long periods of time can transform someone who has relatively lower genetic loading into an addict.
Volkow ND, Koob GF, McLellan AT (January 2016). "Neurobiologic Advances from the Brain Disease Model of Addiction". New England Journal of Medicine. 374 (4): 363–371. doi:10.1056/NEJMra1511480. PMC 6135257. PMID 26816013. Substance-use disorder: A diagnostic term in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) referring to recurrent use of alcohol or other drugs that causes clinically and functionally significant impairment, such as health problems, disability, and failure to meet major responsibilities at work, school, or home. Depending on the level of severity, this disorder is classified as mild, moderate, or severe.
Addiction: A term used to indicate the most severe, chronic stage of substance-use disorder, in which there is a substantial loss of self-control, as indicated by compulsive drug taking despite the desire to stop taking the drug. In the DSM-5, the term addiction is synonymous with the classification of severe substance-use disorder.
Drummond DC (2001). "Theories of drug craving, ancient and modern". Addiction. 96 (1): 33–46. doi:10.1046/j.1360-0443.2001.961333.x. PMID 11177518.
Olsen CM (December 2011). "Natural rewards, neuroplasticity, and non-drug addictions". Neuropharmacology. 61 (7): 1109–22. doi:10.1016/j.neuropharm.2011.03.010. PMC 3139704. PMID 21459101.
Alavi SS, Ferdosi M, Jannatifard F, Eslami M, Alaghemandan H, Setare M (April 2012). "Behavioral Addiction versus Substance Addiction: Correspondence of Psychiatric and Psychological Views". International Journal of Preventive Medicine. 3 (4): 290–294. PMC 3354400. PMID 22624087.
Gearhardt AN, Bueno NB, DiFeliceantonio AG, Roberto CA, Jiménez-Murcia S, Fernandez-Aranda F (October 2023). "Social, clinical, and policy implications of ultra-processed food addiction". BMJ. 383 e075354. doi:10.1136/bmj-2023-075354. PMC 10561019. PMID 37813420.
di Giacomo E, Aliberti F, Pescatore F, Santorelli M, Pessina R, Placenti V, et al. (August 2022). "Disentangling binge eating disorder and food addiction: a systematic review and meta-analysis". Eating and Weight Disorders. 27 (6): 1963–1970. doi:10.1007/s40519-021-01354-7. PMC 9287203. PMID 35041154.
Vassoler FM, Sadri-Vakili G (2014). "Mechanisms of transgenerational inheritance of addictive-like behaviors". Neuroscience. 264: 198–206. doi:10.1016/j.neuroscience.2013.07.064. PMC 3872494. PMID 23920159.
Saunders GR, Wang X, Chen F, Jang SK, Liu M, Wang C, et al. (December 2022). "Genetic diversity fuels gene discovery for tobacco and alcohol use". Nature. 612 (7941). Nature Research: 720–724. Bibcode:2022Natur.612..720S. doi:10.1038/s41586-022-05477-4. PMC 9771818. PMID 36477530. S2CID 254434507.
Skylstad V, Babirye JN, Kiguli J, Skar AS, Kühl MJ, Nalugya JS, et al. (March 2022). "Are we overlooking alcohol use by younger children?". BMJ Paediatrics Open. 6 (1) e001242. doi:10.1136/bmjpo-2021-001242. PMC 8905875. PMID 36053657.
Hughes K, Bellis MA, Hardcastle KA, Sethi D, Butchart A, Mikton C, et al. (August 2017). "The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis". The Lancet. Public Health. 2 (8): e356–e366. doi:10.1016/S2468-2667(17)30118-4. PMID 29253477.
Leza L, Siria S, López-Goñi JJ, Fernández-Montalvo J (April 2021). "Adverse childhood experiences (ACEs) and substance use disorder (SUD): a scoping review". Drug and Alcohol Dependence. 221 108563. doi:10.1016/j.drugalcdep.2021.108563. hdl:2454/39101. PMID 33561668.
Enoch MA (March 2011). "The role of early life stress as a predictor for alcohol and drug dependence". Psychopharmacology. 214 (1): 17–31. doi:10.1007/s00213-010-1916-6. PMC 3005022. PMID 20596857.
Sinha R (August 2024). "Stress and substance use disorders: risk, relapse, and treatment outcomes". The Journal of Clinical Investigation. 134 (16) e172883. doi:10.1172/JCI172883. PMC 11324296. PMID 39145454.
Ruffle JK (November 2014). "Molecular neurobiology of addiction: what's all the (Δ)FosB about?". Am. J. Drug Alcohol Abuse. 40 (6): 428–37. doi:10.3109/00952990.2014.933840. PMID 25083822. S2CID 19157711.
Washburn DA (2016). "The Stroop effect at 80: The competition between stimulus control and cognitive control". J Exp Anal Behav. 105 (1): 3–13. doi:10.1002/jeab.194. PMID 26781048.
Diamond A (2013). "Executive functions". Annu Rev Psychol. 64: 135–68. doi:10.1146/annurev-psych-113011-143750. PMC 4084861. PMID 23020641.
Gould TJ (December 2010). "Addiction and cognition". Addiction Science & Clinical Practice. 5 (2): 4–14. PMC 3120118. PMID 22002448.
Levy N (2019). "Chapter 5 Addiction: The belief oscillation hypothesis". In Pickard H, Ahmed SH (eds.). The Routledge handbook of philosophy and science of addiction. Wellcome Trust–Funded Monographs and Book Chapters. Oxon (UK): Routledge. doi:10.4324/9781315689197-6. ISBN 978-1-138-90928-1. OCLC 1042341025. PMID 31017751. S2CID 242067468.
Berridge KC, Kringelbach ML (May 2015). "Pleasure systems in the brain". Neuron. 86 (3): 646–664. doi:10.1016/j.neuron.2015.02.018. PMC 4425246. PMID 25950633.
Feltenstein MW, See RE (May 2008). "The neurocircuitry of addiction: an overview". British Journal of Pharmacology. 154 (2): 261–274. doi:10.1038/bjp.2008.51. PMC 2442446. PMID 18311189.
Perry CJ, Zbukvic I, Kim JH, Lawrence AJ (October 2014). "Role of cues and contexts on drug-seeking behaviour". British Journal of Pharmacology. 171 (20): 4636–72. doi:10.1111/bph.12735. PMC 4209936. PMID 24749941.
Berridge KC (April 2012). "From prediction error to incentive salience: mesolimbic computation of reward motivation". Eur. J. Neurosci. 35 (7): 1124–43. doi:10.1111/j.1460-9568.2012.07990.x. PMC 3325516. PMID 22487042.
Edwards S (2016). "Reinforcement principles for addiction medicine; from recreational drug use to psychiatric disorder". Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Constructs and Drugs. Progress in Brain Research. Vol. 223. pp. 63–76. doi:10.1016/bs.pbr.2015.07.005. ISBN 978-0-444-63545-7. PMID 26806771.
Robinson TE, Berridge KC (2025). "The Incentive-Sensitization Theory of Addiction 30 Years On". Annual Review of Psychology. 76 (1): 29–58. doi:10.1146/annurev-psych-011624-024031. PMC 11773642. PMID 39094061.
Nestler EJ, Barrot M, Self DW (September 2001). "DeltaFosB: a sustained molecular switch for addiction". Proc. Natl. Acad. Sci. U.S.A. 98 (20): 11042–46. doi:10.1073/pnas.191352698. PMC 58680. PMID 11572966.
Nestler EJ (October 2008). "Review. Transcriptional mechanisms of addiction: role of DeltaFosB". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 363 (1507): 3245–55. doi:10.1098/rstb.2008.0067. PMC 2607320. PMID 18640924.
Nestler EJ (January 2014). "Epigenetic mechanisms of drug addiction". Neuropharmacology. 76 (Pt B): 259–68. doi:10.1016/j.neuropharm.2013.04.004. PMC 3766384. PMID 23643695.
Walker DM, Cates HM, Heller EA, Nestler EJ (February 2015). "Regulation of chromatin states by drugs of abuse". Curr. Opin. Neurobiol. 30: 112–21. doi:10.1016/j.conb.2014.11.002. PMC 4293340. PMID 25486626.
Tiffany ST (1990). "A cognitive model of drug urges and drug-use behavior: Role of automatic and nonautomatic processes". Psychological Review. 97 (2): 147–168. doi:10.1037/0033-295X.97.2.147. ISSN 1939-1471. PMID 2186423.
Cheetham A, Allen NB, Yücel M, Lubman DI (August 2010). "The role of affective dysregulation in drug addiction". Clin Psychol Rev. 30 (6): 621–34. doi:10.1016/j.cpr.2010.04.005. PMID 20546986.
Dawe S, Loxton NJ (May 2004). "The role of impulsivity in the development of substance use and eating disorders". Neurosci Biobehav Rev. 28 (3): 343–51. doi:10.1016/j.neubiorev.2004.03.007. PMID 15225976. S2CID 24435589.
Smith MA (February 2021). "Social learning and addiction". Behavioural Brain Research. 398 112954. doi:10.1016/j.bbr.2020.112954. PMC 7719575. PMID 33053384.
Hunt A, Merola GP, Carpenter T, Jaeggi AV (April 2024). "Evolutionary perspectives on substance and behavioural addictions: Distinct and shared pathways to understanding, prediction and prevention". Neuroscience and Biobehavioral Reviews. 159 105603. doi:10.1016/j.neubiorev.2024.105603. PMID 38402919.
Nesse RM, Berridge KC (October 1997). "Psychoactive drug use in evolutionary perspective". Science. 278 (5335): 63–66. doi:10.1126/science.278.5335.63. PMID 9311928.
Durrant R, Adamson S, Todd F, Sellman D (13 November 2009). "Drug use and addiction: evolutionary perspective". Australian and New Zealand Journal of Psychiatry. 43 (11): 1049–1056. doi:10.3109/00048670903270449. ISSN 0004-8674. PMID 20001400.
Saah T (29 June 2005). "The evolutionary origins and significance of drug addiction". Harm Reduction Journal. 2 (1) 8. doi:10.1186/1477-7517-2-8. ISSN 1477-7517. PMC 1174878. PMID 15987511.
Sullivan RJ, Hagen EH, Hammerstein P (March 2008). "Revealing the paradox of drug reward in human evolution". Proceedings of the Royal Society B: Biological Sciences. 275 (1640): 1231–1241. doi:10.1098/rspb.2007.1673. PMC 2367444. PMID 18353749.
Volkow ND, Koob GF, McLellan AT (28 January 2016). "Neurobiologic Advances from the Brain Disease Model of Addiction". New England Journal of Medicine. 374 (4): 363–371. doi:10.1056/NEJMra1511480. ISSN 0028-4793. PMC 6135257. PMID 26816013.
Petry NM, Rehbein F, Gentile DA, Lemmens JS, Rumpf HJ, Mößle T, et al. (September 2014). "An international consensus for assessing internet gaming disorder using the new DSM-5 approach". Addiction. 109 (9): 1399–406. doi:10.1111/add.12457. PMID 24456155.
Han BH, Moore AA (February 2018). "Prevention and Screening of Unhealthy Substance Use by Older Adults". Clinics in Geriatric Medicine. 34 (1): 117–129. doi:10.1016/j.cger.2017.08.005. PMC 5718360. PMID 29129212.
Yudko E, Lozhkina O, Fouts A (March 2007). "A comprehensive review of the psychometric properties of the Drug Abuse Screening Test". Journal of Substance Abuse Treatment. 32 (2): 189–198. doi:10.1016/j.jsat.2006.08.002. PMID 17306727.
Kwako LE, Momenan R, Litten RZ, Koob GF, Goldman D (August 2016). "Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders". Biological Psychiatry. 80 (3): 179–189. doi:10.1016/j.biopsych.2015.10.024. PMC 4870153. PMID 26772405.
Santo T, Clark B, Hickman M, Grebely J, Campbell G, Sordo L, et al. (September 2021). "Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis". JAMA Psychiatry. 78 (9): 979–993. doi:10.1001/jamapsychiatry.2021.0976. PMC 8173472. PMID 34076676.
Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, et al. (September 2017). "Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs". The Cochrane Database of Systematic Reviews. 2017 (9) CD012021. doi:10.1002/14651858.CD012021.pub2. PMC 5621373. PMID 28922449.
Kelly JF, Humphreys K, Ferri M (March 2020). "Alcoholics Anonymous and other 12-step programs for alcohol use disorder". The Cochrane Database of Systematic Reviews. 2020 (3) CD012880. doi:10.1002/14651858.CD012880.pub2. PMC 7065341. PMID 32159228.
GBD 2016 Alcohol and Drug Use Collaborators (December 2018). "The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016". The Lancet. Psychiatry. 5 (12): 987–1012. doi:10.1016/S2215-0366(18)30337-7. PMC 6251968. PMID 30392731.
Chen CC, Yin SJ (October 2008). "Alcohol abuse and related factors in Asia". International Review of Psychiatry. 20 (5): 425–433. doi:10.1080/09540260802344075. PMID 19012127. S2CID 24571763.
Pacurucu-Castillo SF, Ordóñez-Mancheno JM, Hernández-Cruz A, Alarcón RD (April 2019). "World opioid and substance use epidemic: a Latin American perspective". Psychiatric Research and Clinical Practice. 1 (1): 32–8. doi:10.1176/appi.prcp.20180009. PMC 9175731. PMID 36101564.
Levine HG (1978). "The discovery of addiction: Changing conceptions of habitual drunkenness in America". Journal of Studies on Alcohol. 39 (1): 143–174. doi:10.15288/jsa.1978.39.143. PMID 344994.
Schütz CG, Ramírez-Vizcaya S, Froese T (2018). "The clinical concept of opioid addiction since 1877: Still wanting after all these years". Frontiers in Psychiatry. 9 508. doi:10.3389/fpsyt.2018.00508. PMC 6198080. PMID 30386269.
Gowing L, Ali R, Allsop S, Marsden J, Turf E, West E, et al. (2015). "Global statistics on addictive behaviours: 2014 status report" (PDF). Addiction. 110 (6): 904–919. doi:10.1111/add.12899. PMID 25963869.
Lee C, Ko A, Yang F (2018). "Association of DSM-5 betel-quid use disorder with oral potentially malignant disorder in 6 betel-quid endemic Asian populations". JAMA Psychiatry. 75 (3): 261–269. doi:10.1001/jamapsychiatry.2017.4307. PMC 5885949. PMID 29417149.
Crocq MA (December 2007). Thibaut F (ed.). "Historical and cultural aspects of man's relationship with addictive drugs". Dialogues in Clinical Neuroscience. 9 (4). Laboratoires Servier: 355–361. doi:10.31887/DCNS.2007.9.4/macrocq. OCLC 62869913. PMC 3202501. PMID 18286796. S2CID 12682928.
van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF (July 2013). "Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review". Drug and Alcohol Dependence. 131 (1–2): 23–35. doi:10.1016/j.drugalcdep.2013.02.018. PMID 23490450.
Magnan E, Weyrich M, Miller M, Melnikow J, Moulin A, Servis M, et al. (February 2024). "Stigma against patients with substance use disorders among health care professionals and trainees and stigma-reducing interventions: a systematic review". Academic Medicine. 99 (2): 221–231. doi:10.1097/ACM.0000000000005467. PMID 37801599.
Heath DB (September 1958). "Drinking patterns of the Bolivian Camba". Quarterly Journal of Studies on Alcohol. 19 (3): 491–508. doi:10.15288/qjsa.1958.19.491. PMID 13579177.
Golub A, Johnson BD, Dunlap E (May 2005). "Subcultural evolution and illicit drug use". Addiction Research & Theory. 13 (3): 217–229. doi:10.1080/16066350500053497. PMC 3690817. PMID 23805068.
Hartmann-Boyce J, Cahill K, Hatsukami D, Cornuz J (August 2012). "Nicotine vaccines for smoking cessation". The Cochrane Database of Systematic Reviews. 2012 (8) CD007072. doi:10.1002/14651858.CD007072.pub2. PMC 6486305. PMID 22895958.
Stephenson RJ, Toth I (May 2023). "Anti-cocaine vaccine development: where are we now and where are we going?". Journal of Medicinal Chemistry. 66 (11): 7086–7100. doi:10.1021/acs.jmedchem.3c00366. PMID 37227096.
Qeadan F, McCunn A, Tingey B (2024). "The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysis". Addiction. 120 (2): 236–250. doi:10.1111/add.16679. PMC 11707322. PMID 39415416.
Leggio L, Hendershot CS, Farokhnia M, et al. (December 2023). "GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders". Nature Medicine. 29 (12): 2993–2995. doi:10.1038/s41591-023-02634-8. PMC 12320759. PMID 38001271.

ncbi.nlm.nih.gov

Yu T, Wang M, Zheng J, Guan S, Chen J (April 2026). "Global substance use disorders burden from 1990 to 2021: post-COVID shifts and widening inequalities". Journal of Global Health. 16 04131. doi:10.7189/jogh.16.04131. PMC 13107084. PMID 42026948.
Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJ (September 2021). "Addiction as a brain disease revised: why it still matters, and the need for consilience". Neuropsychopharmacology. 46 (10): 1715–1723. doi:10.1038/s41386-020-00950-y. ISSN 0893-133X. PMC 8357831. PMID 33619327. pre-existing vulnerabilities and persistent drug use lead to a vicious circle of substantive disruptions in the brain that impair and undermine choice capacities for adaptive behavior, but do not annihilate them.
Volkow ND, Blanco C (June 2023). "Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention". World Psychiatry. 22 (2): 203–229. doi:10.1002/wps.21073. PMC 10168177. PMID 37159360.
Nestler EJ (December 2013). "Cellular basis of memory for addiction". Dialogues in Clinical Neuroscience. 15 (4): 431–443. doi:10.31887/DCNS.2013.15.4/enestler. PMC 3898681. PMID 24459410.
Verhulst B, Neale MC, Kendler KS (April 2015). "The heritability of alcohol use disorders: a meta-analysis of twin and adoption studies". Psychological Medicine. 45 (5): 1061–1072. doi:10.1017/S0033291714002165. PMC 4345133. PMID 25171596.
Bogdan R, Hatoum AS, Johnson EC, Agrawal A (January 2023). "The Genetically Informed Neurobiology of Addiction (GINA) model". Nature Reviews Neuroscience. 24 (1): 40–57. doi:10.1038/s41583-022-00656-8. PMC 10041646. PMID 36446900.
MacKillop J, Agabio R, Feldstein Ewing SW, Heilig M, Kelly JF, Leggio L, et al. (December 2022). "Hazardous drinking and alcohol use disorders". Nature Reviews. Disease Primers. 8 (1) 80. doi:10.1038/s41572-022-00406-1. PMC 10284465. PMID 36550121.
Volkow ND, Michaelides M, Baler R (October 2019). "The Neuroscience of Drug Reward and Addiction". Physiological Reviews. 99 (4): 2115–2140. doi:10.1152/physrev.00014.2018. PMC 6890985. PMID 31507244.
Mattick RP, Breen C, Kimber J, Davoli M (February 2014). "Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence". The Cochrane Database of Systematic Reviews. 2014 (2) CD002207. doi:10.1002/14651858.CD002207.pub4. PMC 10617756. PMID 24500948.
McPheeters M, O'Connor EA, Riley S, Kennedy SM, Voisin C, Kuznacic K, et al. (November 2023). "Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis". JAMA. 330 (17): 1653–1665. doi:10.1001/jama.2023.19761. PMC 10630900. PMID 37934220.
Lindson N, Theodoulou A, Ordóñez-Mena JM, Fanshawe TR, Sutton AJ, Livingstone-Banks J, et al. (September 2023). "Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses". The Cochrane Database of Systematic Reviews. 2023 (9) CD015226. doi:10.1002/14651858.CD015226.pub2. PMC 10495240. PMID 37696529.
De Crescenzo F, Ciabattini M, D'Alò GL, De Giorgi R, Del Giovane C, Cassar C, et al. (December 2018). "Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis". PLOS Medicine. 15 (12) e1002715. doi:10.1371/journal.pmed.1002715. PMC 6306153. PMID 30586362.
Colledge-Frisby S, Ottaviano S, Webb P, Grebely J, Wheeler A, et al. (May 2023). "Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review". Lancet Global Health. 11 (5): e673–e683. doi:10.1016/S2214-109X(23)00058-X. PMC 12765503. PMID 36996860.
GBD 2023 Diseases and Injuries Collaborators (October 2025). "Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023". Lancet. 406 (10513): 1873–1922. doi:10.1016/S0140-6736(25)01637-X. PMC 12535840. PMID 41092926.
Merikangas KR, McClair VL (June 2012). "Epidemiology of Substance Use Disorders". Hum. Genet. 131 (6): 779–89. doi:10.1007/s00439-012-1168-0. PMC 4408274. PMID 22543841.
Athey A, Shaff J, Kahn G, Brodie K, Ryan TC, Sawyer H, et al. (March 2025). "Association of substance use with suicide mortality: An updated systematic review and meta-analysis". Drug and Alcohol Dependence Reports. 14 100310. doi:10.1016/j.dadr.2024.100310. PMC 11741031. PMID 39830682.
Destoop M, Morrens M, Coppens V, Dom G (2019). "Addiction, anhedonia, and comorbid mood disorder. A narrative review". Frontiers in Psychiatry. 10 311. doi:10.3389/fpsyt.2019.00311. PMC 6538808. PMID 31178763.
Nestler EJ (December 2013). "Cellular basis of memory for addiction". Dialogues in Clinical Neuroscience. 15 (4): 431–443. PMC 3898681. PMID 24459410. Despite the importance of numerous psychosocial factors, at its core, drug addiction involves a biological process: the ability of repeated exposure to a drug of abuse to induce changes in a vulnerable brain that drive the compulsive seeking and taking of drugs, and loss of control over drug use, that define a state of addiction. ... A large body of literature has demonstrated that such ΔFosB induction in D1-type [nucleus accumbens] neurons increases an animal's sensitivity to drug as well as natural rewards and promotes drug self-administration, presumably through a process of positive reinforcement ... Another ΔFosB target is cFos: as ΔFosB accumulates with repeated drug exposure it represses c-Fos and contributes to the molecular switch whereby ΔFosB is selectively induced in the chronic drug-treated state.⁴¹ ... Moreover, there is increasing evidence that, despite a range of genetic risks for addiction across the population, exposure to sufficiently high doses of a drug for long periods of time can transform someone who has relatively lower genetic loading into an addict.
Volkow ND, Koob GF, McLellan AT (January 2016). "Neurobiologic Advances from the Brain Disease Model of Addiction". New England Journal of Medicine. 374 (4): 363–371. doi:10.1056/NEJMra1511480. PMC 6135257. PMID 26816013. Substance-use disorder: A diagnostic term in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) referring to recurrent use of alcohol or other drugs that causes clinically and functionally significant impairment, such as health problems, disability, and failure to meet major responsibilities at work, school, or home. Depending on the level of severity, this disorder is classified as mild, moderate, or severe.
Addiction: A term used to indicate the most severe, chronic stage of substance-use disorder, in which there is a substantial loss of self-control, as indicated by compulsive drug taking despite the desire to stop taking the drug. In the DSM-5, the term addiction is synonymous with the classification of severe substance-use disorder.
Olsen CM (December 2011). "Natural rewards, neuroplasticity, and non-drug addictions". Neuropharmacology. 61 (7): 1109–22. doi:10.1016/j.neuropharm.2011.03.010. PMC 3139704. PMID 21459101.
Alavi SS, Ferdosi M, Jannatifard F, Eslami M, Alaghemandan H, Setare M (April 2012). "Behavioral Addiction versus Substance Addiction: Correspondence of Psychiatric and Psychological Views". International Journal of Preventive Medicine. 3 (4): 290–294. PMC 3354400. PMID 22624087.
Gearhardt AN, Bueno NB, DiFeliceantonio AG, Roberto CA, Jiménez-Murcia S, Fernandez-Aranda F (October 2023). "Social, clinical, and policy implications of ultra-processed food addiction". BMJ. 383 e075354. doi:10.1136/bmj-2023-075354. PMC 10561019. PMID 37813420.
di Giacomo E, Aliberti F, Pescatore F, Santorelli M, Pessina R, Placenti V, et al. (August 2022). "Disentangling binge eating disorder and food addiction: a systematic review and meta-analysis". Eating and Weight Disorders. 27 (6): 1963–1970. doi:10.1007/s40519-021-01354-7. PMC 9287203. PMID 35041154.
Vassoler FM, Sadri-Vakili G (2014). "Mechanisms of transgenerational inheritance of addictive-like behaviors". Neuroscience. 264: 198–206. doi:10.1016/j.neuroscience.2013.07.064. PMC 3872494. PMID 23920159.
Saunders GR, Wang X, Chen F, Jang SK, Liu M, Wang C, et al. (December 2022). "Genetic diversity fuels gene discovery for tobacco and alcohol use". Nature. 612 (7941). Nature Research: 720–724. Bibcode:2022Natur.612..720S. doi:10.1038/s41586-022-05477-4. PMC 9771818. PMID 36477530. S2CID 254434507.
Skylstad V, Babirye JN, Kiguli J, Skar AS, Kühl MJ, Nalugya JS, et al. (March 2022). "Are we overlooking alcohol use by younger children?". BMJ Paediatrics Open. 6 (1) e001242. doi:10.1136/bmjpo-2021-001242. PMC 8905875. PMID 36053657.
Enoch MA (March 2011). "The role of early life stress as a predictor for alcohol and drug dependence". Psychopharmacology. 214 (1): 17–31. doi:10.1007/s00213-010-1916-6. PMC 3005022. PMID 20596857.
Sinha R (August 2024). "Stress and substance use disorders: risk, relapse, and treatment outcomes". The Journal of Clinical Investigation. 134 (16) e172883. doi:10.1172/JCI172883. PMC 11324296. PMID 39145454.
Diamond A (2013). "Executive functions". Annu Rev Psychol. 64: 135–68. doi:10.1146/annurev-psych-113011-143750. PMC 4084861. PMID 23020641.
Gould TJ (December 2010). "Addiction and cognition". Addiction Science & Clinical Practice. 5 (2): 4–14. PMC 3120118. PMID 22002448.
Levy N (2019). "Chapter 5 Addiction: The belief oscillation hypothesis". In Pickard H, Ahmed SH (eds.). The Routledge handbook of philosophy and science of addiction. Wellcome Trust–Funded Monographs and Book Chapters. Oxon (UK): Routledge. doi:10.4324/9781315689197-6. ISBN 978-1-138-90928-1. OCLC 1042341025. PMID 31017751. S2CID 242067468.
Berridge KC, Kringelbach ML (May 2015). "Pleasure systems in the brain". Neuron. 86 (3): 646–664. doi:10.1016/j.neuron.2015.02.018. PMC 4425246. PMID 25950633.
Feltenstein MW, See RE (May 2008). "The neurocircuitry of addiction: an overview". British Journal of Pharmacology. 154 (2): 261–274. doi:10.1038/bjp.2008.51. PMC 2442446. PMID 18311189.
Perry CJ, Zbukvic I, Kim JH, Lawrence AJ (October 2014). "Role of cues and contexts on drug-seeking behaviour". British Journal of Pharmacology. 171 (20): 4636–72. doi:10.1111/bph.12735. PMC 4209936. PMID 24749941.
Berridge KC (April 2012). "From prediction error to incentive salience: mesolimbic computation of reward motivation". Eur. J. Neurosci. 35 (7): 1124–43. doi:10.1111/j.1460-9568.2012.07990.x. PMC 3325516. PMID 22487042.
Robinson TE, Berridge KC (2025). "The Incentive-Sensitization Theory of Addiction 30 Years On". Annual Review of Psychology. 76 (1): 29–58. doi:10.1146/annurev-psych-011624-024031. PMC 11773642. PMID 39094061.
Nestler EJ, Barrot M, Self DW (September 2001). "DeltaFosB: a sustained molecular switch for addiction". Proc. Natl. Acad. Sci. U.S.A. 98 (20): 11042–46. doi:10.1073/pnas.191352698. PMC 58680. PMID 11572966.
Nestler EJ (October 2008). "Review. Transcriptional mechanisms of addiction: role of DeltaFosB". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 363 (1507): 3245–55. doi:10.1098/rstb.2008.0067. PMC 2607320. PMID 18640924.
Nestler EJ (January 2014). "Epigenetic mechanisms of drug addiction". Neuropharmacology. 76 (Pt B): 259–68. doi:10.1016/j.neuropharm.2013.04.004. PMC 3766384. PMID 23643695.
Walker DM, Cates HM, Heller EA, Nestler EJ (February 2015). "Regulation of chromatin states by drugs of abuse". Curr. Opin. Neurobiol. 30: 112–21. doi:10.1016/j.conb.2014.11.002. PMC 4293340. PMID 25486626.
Smith MA (February 2021). "Social learning and addiction". Behavioural Brain Research. 398 112954. doi:10.1016/j.bbr.2020.112954. PMC 7719575. PMID 33053384.
Saah T (29 June 2005). "The evolutionary origins and significance of drug addiction". Harm Reduction Journal. 2 (1) 8. doi:10.1186/1477-7517-2-8. ISSN 1477-7517. PMC 1174878. PMID 15987511.
Sullivan RJ, Hagen EH, Hammerstein P (March 2008). "Revealing the paradox of drug reward in human evolution". Proceedings of the Royal Society B: Biological Sciences. 275 (1640): 1231–1241. doi:10.1098/rspb.2007.1673. PMC 2367444. PMID 18353749.
Volkow ND, Koob GF, McLellan AT (28 January 2016). "Neurobiologic Advances from the Brain Disease Model of Addiction". New England Journal of Medicine. 374 (4): 363–371. doi:10.1056/NEJMra1511480. ISSN 0028-4793. PMC 6135257. PMID 26816013.
Han BH, Moore AA (February 2018). "Prevention and Screening of Unhealthy Substance Use by Older Adults". Clinics in Geriatric Medicine. 34 (1): 117–129. doi:10.1016/j.cger.2017.08.005. PMC 5718360. PMID 29129212.
Kwako LE, Momenan R, Litten RZ, Koob GF, Goldman D (August 2016). "Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders". Biological Psychiatry. 80 (3): 179–189. doi:10.1016/j.biopsych.2015.10.024. PMC 4870153. PMID 26772405.
Santo T, Clark B, Hickman M, Grebely J, Campbell G, Sordo L, et al. (September 2021). "Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis". JAMA Psychiatry. 78 (9): 979–993. doi:10.1001/jamapsychiatry.2021.0976. PMC 8173472. PMID 34076676.
Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, et al. (September 2017). "Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs". The Cochrane Database of Systematic Reviews. 2017 (9) CD012021. doi:10.1002/14651858.CD012021.pub2. PMC 5621373. PMID 28922449.
Kelly JF, Humphreys K, Ferri M (March 2020). "Alcoholics Anonymous and other 12-step programs for alcohol use disorder". The Cochrane Database of Systematic Reviews. 2020 (3) CD012880. doi:10.1002/14651858.CD012880.pub2. PMC 7065341. PMID 32159228.
GBD 2016 Alcohol and Drug Use Collaborators (December 2018). "The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016". The Lancet. Psychiatry. 5 (12): 987–1012. doi:10.1016/S2215-0366(18)30337-7. PMC 6251968. PMID 30392731.
Pacurucu-Castillo SF, Ordóñez-Mancheno JM, Hernández-Cruz A, Alarcón RD (April 2019). "World opioid and substance use epidemic: a Latin American perspective". Psychiatric Research and Clinical Practice. 1 (1): 32–8. doi:10.1176/appi.prcp.20180009. PMC 9175731. PMID 36101564.
Schütz CG, Ramírez-Vizcaya S, Froese T (2018). "The clinical concept of opioid addiction since 1877: Still wanting after all these years". Frontiers in Psychiatry. 9 508. doi:10.3389/fpsyt.2018.00508. PMC 6198080. PMID 30386269.
Lee C, Ko A, Yang F (2018). "Association of DSM-5 betel-quid use disorder with oral potentially malignant disorder in 6 betel-quid endemic Asian populations". JAMA Psychiatry. 75 (3): 261–269. doi:10.1001/jamapsychiatry.2017.4307. PMC 5885949. PMID 29417149.
Crocq MA (December 2007). Thibaut F (ed.). "Historical and cultural aspects of man's relationship with addictive drugs". Dialogues in Clinical Neuroscience. 9 (4). Laboratoires Servier: 355–361. doi:10.31887/DCNS.2007.9.4/macrocq. OCLC 62869913. PMC 3202501. PMID 18286796. S2CID 12682928.
Golub A, Johnson BD, Dunlap E (May 2005). "Subcultural evolution and illicit drug use". Addiction Research & Theory. 13 (3): 217–229. doi:10.1080/16066350500053497. PMC 3690817. PMID 23805068.
Hartmann-Boyce J, Cahill K, Hatsukami D, Cornuz J (August 2012). "Nicotine vaccines for smoking cessation". The Cochrane Database of Systematic Reviews. 2012 (8) CD007072. doi:10.1002/14651858.CD007072.pub2. PMC 6486305. PMID 22895958.
Qeadan F, McCunn A, Tingey B (2024). "The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with opioid and alcohol use disorders: A real-world data analysis". Addiction. 120 (2): 236–250. doi:10.1111/add.16679. PMC 11707322. PMID 39415416.
Leggio L, Hendershot CS, Farokhnia M, et al. (December 2023). "GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders". Nature Medicine. 29 (12): 2993–2995. doi:10.1038/s41591-023-02634-8. PMC 12320759. PMID 38001271.

nida.nih.gov

"Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) Tool". nida.nih.gov. Archived from the original on 14 August 2022. Retrieved 29 November 2022.

sagepub.com (Global: 609^th place; English: 451^st place)

journals.sagepub.com

Marcos AC, Bahr SJ (June 1988). "Control Theory and Adolescent Drug Use". Youth & Society. 19 (4): 395–425. doi:10.1177/0044118X88019004003. ISSN 0044-118X. S2CID 143860602.

anp.sagepub.com

Durrant R, Adamson S, Todd F, Sellman D (13 November 2009). "Drug use and addiction: evolutionary perspective". Australian and New Zealand Journal of Psychiatry. 43 (11): 1049–1056. doi:10.3109/00048670903270449. ISSN 0004-8674. PMID 20001400.

sciencedirect.com (Global: 137^th place; English: 146^th place)

Fleury MJ, Djouini A, Huỳnh C, Tremblay J, Ferland F, Ménard JM, et al. (1 November 2016). "Remission from substance use disorders: A systematic review and meta-analysis". Drug and Alcohol Dependence. 168: 293–306. doi:10.1016/j.drugalcdep.2016.08.625. ISSN 0376-8716. Retrieved 31 August 2026.

semanticscholar.org (Global: 15^th place; English: 8^th place)

api.semanticscholar.org

Lewis M (October 2018). Longo DL (ed.). "Brain Change in Addiction as Learning, Not Disease". The New England Journal of Medicine. 379 (16): 1551–1560. doi:10.1056/NEJMra1602872. hdl:1807/97270. PMID 30332573. S2CID 205117578.
Saunders GR, Wang X, Chen F, Jang SK, Liu M, Wang C, et al. (December 2022). "Genetic diversity fuels gene discovery for tobacco and alcohol use". Nature. 612 (7941). Nature Research: 720–724. Bibcode:2022Natur.612..720S. doi:10.1038/s41586-022-05477-4. PMC 9771818. PMID 36477530. S2CID 254434507.
Hill R, Harris J (2 November 2021). "Psychological Approaches to Addiction". In Day E (ed.). Seminars in addiction psychiatry (2nd ed.). Cambridge: Cambridge University Press. pp. 147–169. doi:10.1017/9781911623199.009. ISBN 978-1-911623-19-9. S2CID 242036830.
Ruffle JK (November 2014). "Molecular neurobiology of addiction: what's all the (Δ)FosB about?". Am. J. Drug Alcohol Abuse. 40 (6): 428–37. doi:10.3109/00952990.2014.933840. PMID 25083822. S2CID 19157711.
Levy N (2019). "Chapter 5 Addiction: The belief oscillation hypothesis". In Pickard H, Ahmed SH (eds.). The Routledge handbook of philosophy and science of addiction. Wellcome Trust–Funded Monographs and Book Chapters. Oxon (UK): Routledge. doi:10.4324/9781315689197-6. ISBN 978-1-138-90928-1. OCLC 1042341025. PMID 31017751. S2CID 242067468.
Fehrman E, Egan V, Gorban AN, Levesley J, Mirkes EM, Muhammad AK (2019). Personality Traits and Drug Consumption. A Story Told by Data. Springer, Cham. arXiv:2001.06520. doi:10.1007/978-3-030-10442-9. ISBN 978-3-030-10441-2. S2CID 151160405.
Dawe S, Loxton NJ (May 2004). "The role of impulsivity in the development of substance use and eating disorders". Neurosci Biobehav Rev. 28 (3): 343–51. doi:10.1016/j.neubiorev.2004.03.007. PMID 15225976. S2CID 24435589.
Marcos AC, Bahr SJ (June 1988). "Control Theory and Adolescent Drug Use". Youth & Society. 19 (4): 395–425. doi:10.1177/0044118X88019004003. ISSN 0044-118X. S2CID 143860602.
Chen CC, Yin SJ (October 2008). "Alcohol abuse and related factors in Asia". International Review of Psychiatry. 20 (5): 425–433. doi:10.1080/09540260802344075. PMID 19012127. S2CID 24571763.
Sahithya B, Kashyap R (2022). "Sexual Addiction Disorder—a review with recent updates". Journal of Psychosexual Health. 4 (2): 95–101. doi:10.1177/26318318221081080. S2CID 248835855.
Crocq MA (December 2007). Thibaut F (ed.). "Historical and cultural aspects of man's relationship with addictive drugs". Dialogues in Clinical Neuroscience. 9 (4). Laboratoires Servier: 355–361. doi:10.31887/DCNS.2007.9.4/macrocq. OCLC 62869913. PMC 3202501. PMID 18286796. S2CID 12682928.
Rosenthal R, Faris S (February 2019). "The etymology and early history of 'addiction'". Addiction Research & Theory. 27 (5). Taylor & Francis: 437–449. doi:10.1080/16066359.2018.1543412. ISSN 1476-7392. S2CID 150418396.
Burraway J (October 2020). "Addiction". In Stein F, Diemberger H, Stasch R, Robbins J, Sanchez A, Lazar S, Candea M (eds.). Open Encyclopedia of Anthropology. doi:10.29164/20addiction. S2CID 241689890.

surgeongeneral.gov (Global: low place; English: low place)

addiction.surgeongeneral.gov

"Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health" (PDF). Office of the Surgeon General. US Department of Health and Human Services. November 2016. pp. 35–37, 45, 63, 155, 317, 338. Retrieved 28 January 2017.

ucl.ac.uk (Global: 1,187^th place; English: 756^th place)

discovery.ucl.ac.uk

Gowing L, Ali R, Allsop S, Marsden J, Turf E, West E, et al. (2015). "Global statistics on addictive behaviours: 2014 status report" (PDF). Addiction. 110 (6): 904–919. doi:10.1111/add.12899. PMID 25963869.

unodc.org (Global: 2,954^th place; English: 2,575^th place)

United Nations Office on Drugs and Crime, World Health Organization (2018). International Standards on Drug Use Prevention (PDF) (Report) (Second updated ed.). Vienna: United Nations.

web.archive.org (Global: 1^st place; English: 1^st place)

"What are risk factors and protective factors?". National Institute on Drug Abuse. Archived from the original on 30 April 2020. Retrieved 13 December 2017.
American Psychiatric Association (2013). "Substance-Related and Addictive Disorders" (PDF). American Psychiatric Publishing. pp. 1–2. Archived from the original (PDF) on 15 August 2015. Retrieved 8 April 2023. Additionally, the diagnosis of dependence caused much confusion. Most people link dependence with "addiction" when, in fact, dependence can be a normal body response to a substance.
"Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) Tool". nida.nih.gov. Archived from the original on 14 August 2022. Retrieved 29 November 2022.

who.int (Global: 213^th place; English: 314^th place)

icd.who.int

"International Classification of Diseases 11th revision – ICD-11. Disorders due to substance use or addictive behaviours". World Health Organization. Geneva. 2023. Retrieved 10 April 2023.
"International Classification of Diseases 11th revision – ICD-11. Disorders due to substance use". World Health Organization. Geneva. 2023. Retrieved 24 March 2023.

who.int

World Health Organization (2024). Global status report on alcohol and health and treatment of substance use disorders (Report). Geneva: World Health Organization. ISBN 978-92-4-009674-5.

worldcat.org (Global: 4^th place; English: 4^th place)

search.worldcat.org

Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJ (September 2021). "Addiction as a brain disease revised: why it still matters, and the need for consilience". Neuropsychopharmacology. 46 (10): 1715–1723. doi:10.1038/s41386-020-00950-y. ISSN 0893-133X. PMC 8357831. PMID 33619327. pre-existing vulnerabilities and persistent drug use lead to a vicious circle of substantive disruptions in the brain that impair and undermine choice capacities for adaptive behavior, but do not annihilate them.
Levy N (2019). "Chapter 5 Addiction: The belief oscillation hypothesis". In Pickard H, Ahmed SH (eds.). The Routledge handbook of philosophy and science of addiction. Wellcome Trust–Funded Monographs and Book Chapters. Oxon (UK): Routledge. doi:10.4324/9781315689197-6. ISBN 978-1-138-90928-1. OCLC 1042341025. PMID 31017751. S2CID 242067468.
Tiffany ST (1990). "A cognitive model of drug urges and drug-use behavior: Role of automatic and nonautomatic processes". Psychological Review. 97 (2): 147–168. doi:10.1037/0033-295X.97.2.147. ISSN 1939-1471. PMID 2186423.
Marcos AC, Bahr SJ (June 1988). "Control Theory and Adolescent Drug Use". Youth & Society. 19 (4): 395–425. doi:10.1177/0044118X88019004003. ISSN 0044-118X. S2CID 143860602.
Durrant R, Adamson S, Todd F, Sellman D (13 November 2009). "Drug use and addiction: evolutionary perspective". Australian and New Zealand Journal of Psychiatry. 43 (11): 1049–1056. doi:10.3109/00048670903270449. ISSN 0004-8674. PMID 20001400.
Saah T (29 June 2005). "The evolutionary origins and significance of drug addiction". Harm Reduction Journal. 2 (1) 8. doi:10.1186/1477-7517-2-8. ISSN 1477-7517. PMC 1174878. PMID 15987511.
Volkow ND, Koob GF, McLellan AT (28 January 2016). "Neurobiologic Advances from the Brain Disease Model of Addiction". New England Journal of Medicine. 374 (4): 363–371. doi:10.1056/NEJMra1511480. ISSN 0028-4793. PMC 6135257. PMID 26816013.
Fleury MJ, Djouini A, Huỳnh C, Tremblay J, Ferland F, Ménard JM, et al. (1 November 2016). "Remission from substance use disorders: A systematic review and meta-analysis". Drug and Alcohol Dependence. 168: 293–306. doi:10.1016/j.drugalcdep.2016.08.625. ISSN 0376-8716. Retrieved 31 August 2026.
Rockwell P, Dunham M (January 2006). "The Utility of the Formal Elements Art Therapy Scale in Assessment for Substance Use Disorder". Art Therapy. 23 (3): 104–111. doi:10.1080/07421656.2006.10129625. ISSN 0742-1656.
Megranahan K, Lynskey MT (February 2018). "Do creative arts therapies reduce substance misuse? A systematic review". The Arts in Psychotherapy. 57: 50–58. doi:10.1016/j.aip.2017.10.005. ISSN 0197-4556.
Crocq MA (December 2007). Thibaut F (ed.). "Historical and cultural aspects of man's relationship with addictive drugs". Dialogues in Clinical Neuroscience. 9 (4). Laboratoires Servier: 355–361. doi:10.31887/DCNS.2007.9.4/macrocq. OCLC 62869913. PMC 3202501. PMID 18286796. S2CID 12682928.
Rosenthal R, Faris S (February 2019). "The etymology and early history of 'addiction'". Addiction Research & Theory. 27 (5). Taylor & Francis: 437–449. doi:10.1080/16066359.2018.1543412. ISSN 1476-7392. S2CID 150418396.
Henningfield JE, Dowell ML, Santora PB (2010). Addiction and Art. Baltimore: Johns Hopkins University Press. ISBN 978-1-4214-0023-5. OCLC 794700340.
Preble E, Casey JJ (January 1969). "Taking Care of Business—The Heroin User's Life on the Street". International Journal of the Addictions. 4 (1): 1–24. doi:10.3109/10826086909061998. ISSN 0020-773X.

Addiction (English Wikipedia)

adsabs.harvard.edu (Global: 14th place; English: 9th place)

ui.adsabs.harvard.edu

anthroencyclopedia.com (Global: low place; English: low place)

apa.org (Global: 1,327th place; English: 1,093rd place)

doi.apa.org

arxiv.org (Global: 49th place; English: 31st place)

books.google.com (Global: 3rd place; English: 3rd place)

cdc.gov (Global: 251st place; English: 248th place)

crafft.org (Global: low place; English: low place)

doi.org (Global: 2nd place; English: 2nd place)

drugabuse.gov (Global: low place; English: 9,769th place)

dsm5.org (Global: low place; English: low place)

hdl.handle.net (Global: 66th place; English: 34th place)

incb.org (Global: low place; English: low place)

nih.gov (Global: 5th place; English: 5th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

nida.nih.gov

sagepub.com (Global: 609th place; English: 451st place)

journals.sagepub.com

anp.sagepub.com

sciencedirect.com (Global: 137th place; English: 146th place)

semanticscholar.org (Global: 15th place; English: 8th place)

api.semanticscholar.org

surgeongeneral.gov (Global: low place; English: low place)

addiction.surgeongeneral.gov

ucl.ac.uk (Global: 1,187th place; English: 756th place)

discovery.ucl.ac.uk

unodc.org (Global: 2,954th place; English: 2,575th place)

web.archive.org (Global: 1st place; English: 1st place)

who.int (Global: 213th place; English: 314th place)

icd.who.int

who.int

worldcat.org (Global: 4th place; English: 4th place)

search.worldcat.org

adsabs.harvard.edu (Global: 14^th place; English: 9^th place)

apa.org (Global: 1,327^th place; English: 1,093^rd place)

arxiv.org (Global: 49^th place; English: 31^st place)

books.google.com (Global: 3^rd place; English: 3^rd place)

cdc.gov (Global: 251^st place; English: 248^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

drugabuse.gov (Global: low place; English: 9,769^th place)

hdl.handle.net (Global: 66^th place; English: 34^th place)

nih.gov (Global: 5^th place; English: 5^th place)

sagepub.com (Global: 609^th place; English: 451^st place)

sciencedirect.com (Global: 137^th place; English: 146^th place)

semanticscholar.org (Global: 15^th place; English: 8^th place)

ucl.ac.uk (Global: 1,187^th place; English: 756^th place)

unodc.org (Global: 2,954^th place; English: 2,575^th place)

web.archive.org (Global: 1^st place; English: 1^st place)

who.int (Global: 213^th place; English: 314^th place)

worldcat.org (Global: 4^th place; English: 4^th place)